0.0920
-0.0280
(-23.33%)
As of February 28 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-2,472.4640
-1,861.7110
-1,916.8600
-2,308.1830
Investing Cash Flow
--
--
--
800
Financing Cash Flow
1,914.1850
1,401.1930
2.1500
4,319.7170
End Cash Position
255.0490
436.3130
896.8310
2,811.5410
Issuance of Capital Stock
--
--
--
4,294.7170
Issuance of Debt
--
1,514
--
--
Free Cash Flow
-2,472.4640
-1,861.7110
-1,916.8600
-2,308.1830
12/31/2021 - 4/8/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CAMP CAMP4 THERAPEUTICS CORPORATION
4.7250
-3.77%
JUNS Jupiter Neurosciences, Inc.
0.6346
-2.52%
CARM Carisma Therapeutics, Inc.
0.4113
+2.57%
AFMD Affimed N.V.
0.9822
-4.64%
INKT MiNK Therapeutics, Inc.
8.73
-2.46%
VOR Vor Biopharma Inc.
1.0000
-7.41%
TNFA TNF Pharmaceuticals, Inc.
0.4050
-3.13%
LRMR Larimar Therapeutics, Inc.
2.8150
-7.10%
CLSD Clearside Biomedical, Inc.
0.8714
+1.36%
ABSI Absci Corporation
3.5500
-7.79%